Announcement Acc. To §§ 37v-x WpHG: Epigenomics AG: Announcement Acc. To §§ 37v-x WpHG With The Aim Of Pan-european Distribution

Berlin, Germany, Mar 13, 2008 - (ABN Newswire) - Epigenomics AG / Epigenomics AG: Announcement according to §§ 37v, 37w, 37x, 37y WpHG with the aim of European-wide distribution Publication of announcement acc.to §§37 v-x ff. WpHG processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------



Advance announcement on the disclosure of financial statements by Epigenomics AG.

Epigenomics AG hereby announces that in the fiscal year 2008 the following financial reports will be disclosed:

Annual financial report of the group 2007 ("Annual Report 2007") Date of disclosure: March 31, 2008

Financial report of the group for the period ending March 31, 2008 ("3-Month-Report") Date of disclosure: May 06, 2008

Financial report of the group for the period ending June 30, 2008 ("6-Month-Report") Date of disclosure: August 05, 2008

Financial report of the group for the period ending September 30, 2008 ("9-Month-Report") Date of disclosure: November 04, 2008

All of the above mentioned financial reports will be published in German and English language on Epigenomics internet website: Place (German financial reports): http://www.epigenomics.com/de/investorrelations/Finanz_Daten/

Place (English financial reports): http://www.epigenomics.com/en/investor_relations/Financial_Information/ Epigenomics' Financial Statement as of and for the year ended December 31, 2007 prepared according to the German Commercial Code (Handelsgesetzbuch) is available for inspection at the premises of the issuer during regular business hours from March 31, 2008 onwards. It also will be published in the Federal Electronic Gazette (elektronischer Bundesanzeiger) and transmitted to the Company Register (Unternehmensregister).

Date of announcement: March 13, 2008

Issuer: Epigenomics AG ISIN: DE000A0BVT9 Kleine Präsidentenstr. 1 10178 Berlin Deutschland Contact: Dr. Achim Plum Vice President Corporate Communications Tel.: +49 (0)30 24345 368 Fax: +49 (0)30 24345 555 Email: ir@epigenomics.com

--- End of Message ---

Epigenomics AG Kleine Präsidentenstr.1 Berlin Germany
WKN: A0BVT9; ISIN: DE000A0BVT96; Index: CDAX, Prime All Share, TECH All Share; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart;

Copyright © Hugin AS 2008. All rights reserved.

Epigenomics AG

http://www.epigenomics.de

ISIN: DE000A0BVT96

Stock Identifier: XFRA.ECX